Finprega NT 75mg/10mg Tablet
Marketer
Biofin Lifesciences
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Finprega NT 75mg/10mg Tablet
Neuropathic pain is treated with the combined medication, Finprega NT 75mg/10mg Tablet. This medication alleviates pain by interrupting the transmission of pain signals to the brain. Administered orally, Finprega NT 75mg/10mg Tablets can be taken with or without food, ideally before sleep, at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Common side effects may include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness are also possible, so avoid driving or mentally demanding tasks until the effects are known. Weight gain may occur; counter this with regular exercise and a balanced diet. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all current medications, as interactions may impact efficacy or functionality. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Finprega NT 75mg/10mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Finprega NT 75mg/10mg Tablet
Managing neuropathic pain
Major Benefits of Finprega NT 75mg/10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Finprega NT 75mg/10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Finprega NT 75mg/10mg Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Finprega NT 75mg/10mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Finprega NT 75mg/10mg Tablets can be administered with or without food, though consistent timing is recommended.
How Finprega NT 75mg/10mg Tablet works:
Finprega NT 75mg/10mg tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain transmission by modulating nerve cell calcium channels. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal propagation in the central nervous system. This combined action provides effective relief from nerve damage-induced pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Finprega NT 75mg/10mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Finprega NT 75mg/10mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Finprega NT 75mg/10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Finprega NT 75mg/10mg Tablets, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with kidney impairment should use Finprega NT 75mg/10mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of the 75mg/10mg Finprega NT Tablet in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Finprega NT 75mg/10mg Tablet :
Should you forget a Finprega NT 75mg/10mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Finprega NT 75mg/10mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Nervous system medication |
FAQs on Finprega NT 75mg/10mg Tablet
The combined medication Finprega NT 75mg/10mg Tablet, containing Pregabalin and Nortriptyline, provides relief from nerve pain (neuropathic pain). Its mechanism involves central nervous system modulation, reducing pain signals originating from damaged or hyperactive nerves.
Discontinuing Finprega NT 75mg/10mg Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may result in withdrawal effects including, but not limited to, anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Finprega NT 75mg/10mg Tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging portion sizes. Restrict high-calorie foods like sugary drinks, fried items, crisps, pastries, and confectionery. Between meals, choose fruits, vegetables, and low-calorie snacks over junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may mitigate weight increase.
Finprega NT 75mg/10mg Tablets can induce drowsiness or cause sudden sleep onset during routine activities. This sleepiness may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks, especially initially, until the medication's effects are understood. Report any such incidents to your physician.
Finprega NT 75mg/10mg Tablet may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these issues arise, but do not discontinue Finprega NT 75mg/10mg Tablet without medical advice.
Finprega NT 75mg/10mg Tablet rarely produces serious adverse reactions. However, if you experience altered body temperature, respiratory distress, rapid heartbeat, weakness, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thought patterns, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or signs of recurrent infections (like fever, intense chills, pharyngitis, or oral ulcers), seek immediate medical care. While infrequent, these side effects warrant prompt professional attention.
Patients may experience initial improvements with Finprega NT 75mg/10mg Tablet within two weeks, although complete therapeutic effects might require two to three months. In certain individuals, a longer timeframe may be necessary.
Should you miss a scheduled dose of Finprega NT 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your usual dosing regimen. Avoid doubling up on doses to compensate for a missed one, as this elevates the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room for assessment. This is crucial even in the absence of noticeable symptoms or suspected toxicity. Immediate medical intervention may be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve results; it could, however, heighten the risk of severe adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for a reassessment.
Taking Finprega NT 75mg/10mg Tablets might affect your cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment with Finprega NT 75mg/10mg Tablets, as it can intensify the medication's effects, posing a safety risk. Grapefruit and its juice can interact negatively with this medication, potentially leading to adverse reactions. Limit sun exposure and the use of tanning beds. Finprega NT 75mg/10mg Tablets can increase sun sensitivity, raising your risk of sunburn. When outdoors during daylight hours, wear protective clothing and apply sunscreen.
Regular monitoring by your physician may be necessary following commencement of Finprega NT 75mg/10mg Tablet treatment. Consult your doctor immediately if your symptoms fail to improve with the prescribed dosage of Finprega NT 75mg/10mg Tablets, or if you experience persistent adverse effects impacting your daily life.
Retain the tablets in their original packaging until needed. Store in a cool, dry location. Keep out of the reach and view of children. Dispose of any remaining medication properly to prevent accidental ingestion by children, pets, or others.
A single tablet of Finprega NT 75mg/10mg combines pregabalin and nortriptyline to manage neuropathic pain. Its mechanism involves central nervous system action to soothe hyperactive or injured nerves, thus reducing pain perception.
Discontinuing Finprega NT 75mg/10mg Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Finprega NT 75mg/10mg tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without larger portions. Avoid high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may prevent any weight increase.
Finprega NT 75mg/10mg Tablets can induce drowsiness or cause sudden sleep onset during routine tasks. This may occur without prior warning signs like drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially initially, until the drug's effects are understood. Report any such incidents to your physician.
Finprega NT 75mg/10mg Tablets may impact sexual function in both genders. Reported side effects frequently include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if such issues arise, but do not discontinue Finprega NT 75mg/10mg Tablet use without medical advice.
Finprega NT 75mg/10mg Tablet rarely produces severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, illogical thought patterns, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or indicators of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions warrant prompt medical intervention.
Patients may notice an improvement in their condition with Finprega NT 75mg/10mg Tablet within two weeks. Complete symptom relief typically manifests within two to three months, although a longer timeframe may be necessary for some individuals.
Should you miss a scheduled dose of Finprega NT 75mg/10mg Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon recollection, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this elevates the risk of adverse reactions from exceeding the prescribed amount. In case of uncertainty, seek guidance from your physician on how to proceed.
If this occurs, promptly contact your physician or proceed to the closest emergency room for assessment. This is crucial even in the absence of noticeable symptoms or suspected intoxication. Immediate medical care may be necessary. Overdose indicators can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, visual blurring, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage won't necessarily improve results; instead, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Finprega NT 75mg/10mg Tablets might affect your cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment with Finprega NT 75mg/10mg Tablets as it can intensify alcoholic effects, posing a safety risk. Grapefruit and its juice can interact negatively with this medication, potentially leading to adverse reactions. Limit sun exposure and the use of tanning beds. Finprega NT 75mg/10mg Tablets can increase sun sensitivity, resulting in sunburn. Protective clothing and sunscreen are recommended for daytime outdoor activities.
Regular monitoring by your physician may be necessary following the commencement of Finprega NT 75mg/10mg Tablet therapy. Seek immediate medical attention if your symptoms persist despite adhering to the prescribed Finprega NT 75mg/10mg Tablet dosage, or if adverse effects significantly impact your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry location. Keep the medication inaccessible to children. Unneeded drugs must be disposed of properly to prevent accidental ingestion by children, pets, or others.
The combination medication Finprega NT 75mg/10mg Tablet, containing pregabalin and nortriptyline, provides relief from neuropathic pain. Its mechanism involves central nervous system action to modulate the activity of damaged or hyperexcitable nerves, thus reducing pain perception.
Discontinuing Finprega NT 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may result in withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Finprega NT 75mg/10mg tablets may increase appetite, potentially leading to weight gain. Preventing weight gain is simpler than subsequent weight loss. Maintain a nutritious, balanced diet without enlarging portions. Avoid high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may help avoid weight increase.
Finprega NT 75mg/10mg Tablets can induce drowsiness or cause sudden sleep onset during everyday tasks. This may occur without prior warning signs of drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are understood. Report any such incidents to your physician.
Finprega NT 75mg/10mg Tablets may impact sexual function in both genders. Reported side effects frequently include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these issues arise; however, do not discontinue Finprega NT 75mg/10mg Tablets without medical advice.
Finprega NT 75mg/10mg Tablet rarely causes severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, breathing difficulties, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or exhilaration), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, vision problems, or signs of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions require prompt medical intervention.
Patients may experience initial improvements with Finprega NT 75mg/10mg Tablets within two weeks, though complete therapeutic effects typically manifest after two to three months. In some cases, a longer duration may be necessary.
Should you miss a scheduled dose of Finprega NT 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If your next dose is not immediately approaching, take the missed dose as soon as you recall, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this elevates the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room for assessment. Seek medical help regardless of the presence or absence of adverse effects. Immediate medical intervention may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; instead, it could significantly raise your risk of adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek immediate medical advice for reassessment.
Taking Finprega NT 75mg/10mg Tablets might affect your cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment with Finprega NT 75mg/10mg Tablets, as it may intensify alcohol's effects, posing potential risks. Grapefruit and its juice can interact negatively with this medication, potentially leading to adverse reactions. Limit sun exposure and avoid tanning beds, as Finprega NT 75mg/10mg Tablets can increase sun sensitivity. Protective clothing and sunscreen are recommended during daylight hours.
Regular check-ups with your physician may be necessary following commencement of Finprega NT 75mg/10mg Tablet therapy. Consult your doctor immediately if your condition doesn't improve with the prescribed dosage of Finprega NT 75mg/10mg Tablets or if you experience persistent adverse effects impacting your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry environment. Keep the medication out of the view and reach of children. Proper disposal of any remaining medicine is necessary to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Finprega NT 75mg/10mg Tab...
179
MRP 218
17% off